Nebraska Center for Substance Abuse Research

Medicine & Life Sciences

1. HIV 100%
2. HIV-1 94%
3. Cocaine 84%
4. Astrocytes 52%
5. Neurocognitive Disorders 46%
6. Morphine 44%
7. Becaplermin 41%
8. Extracellular Vesicles 39%
9. Autophagy 35%
10. Substance-Related Disorders 34%
11. Microglia 32%
12. Platelet-Derived Growth Factor 30%
13. Trans-Activators 28%
14. Brain 25%
15. Human Immunodeficiency Virus Proteins 21%
16. MicroRNAs 21%
17. Transgenic Rats 20%
18. Simian Immunodeficiency Virus 20%
19. sigma-1 receptor 20%
20. Pericytes 19%
21. HIV Infections 18%
22. Endoplasmic Reticulum Stress 18%
23. Macaca mulatta 18%
24. Neurogenesis 16%
25. Proto-Oncogene Proteins c-sis 16%
26. NF-kappa B 16%
27. Neurons 15%
28. Monocytes 15%
29. Macaca 15%
30. Central Nervous System 14%
31. Blood-Brain Barrier 14%
32. Up-Regulation 14%
33. Nervous System Diseases 13%
34. Therapeutics 13%
35. Neurodegenerative Diseases 12%
36. Endothelial Cells 12%
37. Virus Diseases 12%
38. Mitophagy 12%
39. Opioid Analgesics 11%
40. Cocaine-Related Disorders 11%
41. Intercellular Signaling Peptides and Proteins 11%
42. Proteins 11%
43. Neuroaid 11%
44. Pharmacology 10%
45. Down-Regulation 10%
46. Long Noncoding RNA 9%
47. Glycogen Synthase Kinase 3 9%
48. sigma Receptors 9%
49. Monocyte Chemoattractant Proteins 9%
50. Neuroglia 9%
51. Viral Proteins 9%
52. Inflammation 9%
53. Exosomes 8%
54. Reactive Oxygen Species 8%
55. Catenins 8%
56. Stem Cells 8%
57. Mitogen-Activated Protein Kinases 8%
58. Lung 8%
59. AIDS Dementia Complex 8%
60. Phosphatidylinositol 3-Kinases 7%
61. Transient Receptor Potential Channels 7%
62. HIV Envelope Protein gp120 7%
63. Epithelial Cells 7%
64. Genes 7%
65. Interleukin-6 7%
66. Inflammasomes 7%
67. Oxidative Stress 6%
68. Neuroprotection 6%
69. Mucus 6%
70. Nicotinic Receptors 6%
71. Capillary Permeability 6%
72. Apoptosis 6%
73. Interleukin-17 6%
74. Cytokines 6%
75. Comorbidity 6%
76. Chemokines 6%
77. Glial Fibrillary Acidic Protein 5%
78. Dysbiosis 5%
79. Macrophages 5%
80. Viruses 5%
81. Self Administration 5%
82. Acquired Immunodeficiency Syndrome 5%
83. Human immunodeficiency virus 1 vpr protein 5%
84. Cell Proliferation 5%
85. In Vitro Techniques 5%
86. Human immunodeficiency virus 1 gp120 protein 5%
87. Transcriptional Activation 5%
88. Permeability 5%
89. Multiple Sclerosis 5%
90. Western Blotting 5%
91. human CCL2 protein 5%
92. Infections 5%
93. human BDNF protein 5%
94. Virus Replication 5%
95. Muscarinic M4 Receptors 5%